764 results on '"Oelke, Matthias"'
Search Results
2. From BPH to male LUTS: a 20-year journey of the EAU guidelines
3. Minimalinvasive Therapien des benignen Prostatasyndroms: Die deutsche S2e-Leitlinie 2023 – Teil 4/4
4. Operative Therapie des benignen Prostatasyndroms – klassische Desobstruktion: Die deutsche S2e-Leitlinie 2023 – Teil 3
5. Konservative und medikamentöse Therapie des benignen Prostatasyndroms: Die deutsche S2e-Leitlinie 2023 – Teil 2
6. Diagnostik des benignen Prostatasyndroms: Die deutsche S2e-Leitlinie 2023 Teil 1
7. Medical Treatment Incidence and Persistence After Surgical Relief of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: A Critical Analysis of the Literature
8. Imaging Techniques for the Benign Prostate Syndrome
9. Prevention of Benign Prostate Syndrome
10. Basic Urodynamic Tests
11. Bildgebende Verfahren beim benignen Prostatasyndrom
12. Prävention des Benignen Prostatasyndroms
13. Spezielle Urodynamik Urodynamik des Mannes des Mannes
14. Messung des Leak Point Pressure
15. Entleerungsstörungen
16. Druck-Fluss-Messung
17. Sonografische Diagnostik des Harntrakts und Beckens
18. Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression
19. Impact of obesity on perioperative, functional and oncological outcomes after robotic-assisted radical prostatectomy in a high-volume center
20. What Are Realistic Expectations to Become Free of Overactive Bladder Symptoms? Experience from Non-interventional Studies with Propiverine
21. Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S)
22. Physiology and Pharmacology of the Prostate
23. Spezielle Urodynamik des Mannes
24. Impact of early vs. delayed initiation of dutasteride/tamsulosin combination therapy on the risk of acute urinary retention or BPH-related surgery in LUTS/BPH patients with moderate-to-severe symptoms at risk of disease progression
25. Strategies for Safe Transurethral Injections of Botulinum Toxin into the Bladder Wall.
26. Minimally invasive treatment of benign prostatic hyperplasia
27. Die Alken-Stadien – eine deutsch-französische Affäre
28. Surgical treatment options of lower urinary tract symptoms due to benign prostatic obstruction
29. Modeling study of the effect of placebo and medical therapy on storage and voiding symptoms, nocturia, and quality of life in men with prostate enlargement at risk for progression
30. Medical Treatment Incidence and Persistence After Surgical Relief of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: A Critical Analysis of the Literature
31. What uro-gynecologists should know about sacral neuromodulation (SNM) for the treatment of refractory overactive bladder
32. Do patient characteristics predict which patients with overactive bladder benefit from a higher fesoterodine dose?
33. Annual direct and indirect costs attributable to nocturia in Germany, Sweden, and the UK
34. From BPH to male LUTS: a 20-year journey of the EAU guidelines
35. Male Lower Urinary Tract Symptoms (MLUTS)
36. Renal cell cancer after kidney transplantation
37. LBA01-02 IMPACT OF MEDICAL TREATMENT ON STORAGE VS VOIDING SYMPTOMS AND NOCTURIA FREQUENCY: A DYNAMIC NOMOGRAM N=9167 MEN WITH PROSTATIC ENLARGEMENT
38. Bladder Instillation Therapy With Hyaluronic Acid and Chondroitin Sulfate Improves Symptoms of Postradiation Cystitis: Prospective Pilot Study
39. Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases
40. Effects of Tadalafil Once-Daily or On-Demand vs Placebo on Return to Baseline Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy – Results from a Randomized Controlled Trial (REACTT)
41. Diagnostic Work-up of LUTS/BPH: From Standard to New Perspectives
42. Contributors
43. Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making
44. Bilateral Peritoneal Flaps Reduce Incidence and Complications of Lymphoceles After Robotic Radical Prostatectomy With Pelvic Lymph Node Dissection—Results of the Prospective Randomized Multicenter Trial ProLy. Reply.
45. Time to Onset of Clinically Meaningful Improvement with Tadalafil 5 mg Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Analysis of Data Pooled from 4 Pivotal, Double-Blind, Placebo Controlled Studies
46. Diagnosis and Therapy of Female Urinary Incontinence. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 015/091, January 2022): Part 2 with Recommendations on Interventional/Surgical Therapy of Overactive Bladder, Surgical Treatment of Stress Urinary Incontinence and Diagnosis and Therapy of Iatrogenic Urogenital Fistula
47. Diagnosis and Therapy of Female Urinary Incontinence. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/091, January 2022): Part 1 with Recommendations on Diagnostics and Conservative and Medical Treatment
48. Ultrasound detrusor wall thickness measurement in combination with bladder capacity can safely detect detrusor underactivity in adult men
49. The Role of Bladder Outlet Obstruction in Male Non-neurogenic Lower Urinary Tract Symptoms—Any Additional News?
50. Transurethral water vapor ablation of the prostate with the Rezūm system: Urodynamic findings
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.